Skip to main content
University of Wisconsin–Madison
Waisman Center
Alexander Disease Lab
Waisman Center, University of Wisconsin-Madison
  • Home
  • Bibliography and Questions Expand Collapse
    • Comprehensive Research Bibliography
    • Unresolved Questions
  • GFAP Mutations Expand Collapse
    • Diagram of Mutations
    • Table of Mutations (Word Document)
  • Related Links
  • Legal Information
  • Donate
  • Presentations
  • AxD Book
  • Publications
  1. Home
  2. An in vivo pharmacological screen identifies cholinergic signaling as a therapeutic target in glial-based nervous system disease

An in vivo pharmacological screen identifies cholinergic signaling as a therapeutic target in glial-based nervous system disease

Messing, VMD, PhD, A. An in Vivo Pharmacological Screen Identifies Cholinergic Signaling As a Therapeutic Target in Glial-Based Nervous System Disease.

Wang L, Hagemann TL, Messing A, Feany MB (2016). An in vivo pharmacological screen identifies cholinergic signaling as a therapeutic target in glial-based nervous system disease. Journal of Neuroscience, 36, 1445-1455

Site footer content

University logo that links to main university website

Website feedback, questions or accessibility issues: lrrowley@wisc.edu.

Learn more about accessibility at UW–Madison.

This site was built using the UW Theme | Privacy Notice | © 2023 Board of Regents of the University of Wisconsin System.